Cargando…
A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
OBJECTIVE: To assess the efficacy and safety of infliximab versus placebo in the treatment of patients with juvenile-onset spondyloarthritis (JoSpA). METHODS: Phase III, randomized, double-blind, placebo-controlled trial of 12 weeks that included patients ≤ 18 years old with JoSpA not responding to...
Autores principales: | Burgos-Vargas, Rubén, Loyola-Sanchez, Adalberto, Ramiro, Sofia, Reding-Bernal, Arturo, Alvarez-Hernandez, Everardo, van der Heijde, Desirée, Vázquez-Mellado, Janitzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358905/ https://www.ncbi.nlm.nih.gov/pubmed/35941676 http://dx.doi.org/10.1186/s13075-022-02877-9 |
Ejemplares similares
-
Outcomes in Juvenile-Onset Spondyloarthritis
por: Smith, Judith A., et al.
Publicado: (2021) -
Occasional presence of herpes viruses in synovial fluid and blood from patients with rheumatoid arthritis and axial spondyloarthritis
por: Burgos, Rubén, et al.
Publicado: (2015) -
Editorial: Juvenile Spondyloarthritis: From Basic Science to Clinical Translation
por: Harjacek, Miroslav, et al.
Publicado: (2022) -
Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference
por: Sepriano, Alexandre, et al.
Publicado: (2021) -
The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist
por: Burgos-Vargas, Ruben
Publicado: (2012)